FiercePharma sits down with the President of Xcenda, Kristine Flemister, to discuss how technology is helping to commercialize new therapies, develop value propositions and expand market access.
FiercePharma sits down with the President of Xcenda, Kristine Flemister, to discuss how technology is helping to commercialize new therapies, develop value propositions and expand market access.